Delivery Order SPE2DB22D1017-SPE2DB25FYNZS
Award Date 8/25/25
Potential Completion Date 8/26/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a Delivery Order valued at $24,066.84 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed price, competitively awarded contract (no set-aside designation) will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency (DLA) awarded a $35,941.65 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-tablet units) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract supporting federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at...
- The Defense Logistics Agency awarded a $5,249.48 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of RINVOQ ER 15 MG tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a performance completion date of August 19, 2025. AmerisourceBergen Drug Corp will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $4,265.94 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 26, 2025, with completion targeted for August 27, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $58,100.78 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on May 5, 2025, with an ultimate completion date of May 6, 2025. This firm fixed price, non-set-aside delivery order represents a purchase of pharmaceutical inventory to support federal medical procurement needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $7,101.17 to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed price, non-set-aside contract represents a routine pharmaceutical delivery under the company's broader federal contracting relationship with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $15,679.59 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $32,555.23 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $11,404.73 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on June 6, 2025, with completion scheduled for June 9, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract carries no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,611.68 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...